Loading stock analysis…
Evidence Synthesis
Last synthesized: 21 Oct 2026, 11:05
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence velocity
Rate-of-change signals for this ticker unlock with Pro — or view flagship demos TCS / RELIANCE.
Evidence Synthesis
Veer Healthcare Sees Strong Growth in Marginal Operating Leverage and Gross Margin.
The company's marginal operating leverage accelerated to , up from 2.87%. Meanwhile, its gross margin accelerated to , up from 6.81%. Additionally, revenue growth has accelerated to , up from 375%.
Despite this, daily trading volume has seen a decline, moving from 98332 shares to 42685 shares. The stock price has also seen a minor increase, closing at 49.16 INR, up from 49.12 INR.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 23.03 % | 6.81 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 6.81 % | 2.87 | ▲ |
| REVENUE_GROWTH_YOY | 388.5 % | 375 | ▲ |
| PRICE_CHANGE_PERCENT | 0.081 % | — | - |
| DAILY_VOLUME | 42,685 shares | 98,332 | ▼ |
| CLOSE_PRICE | 49.16 INR | 49.12 | ▲ |
Cite this
Source: Samhati evidence synthesis for VEERHEALTH (2026-10-21). Observation: Veer Healthcare Sees Strong Growth in Marginal Operating Leverage and Gross Margin. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/veerhealth
Filing step-changes